IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva

URBINATI, Chiara Eva  

Mostra records
Risultati 1 - 20 di 91 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 1-gen-1996 Rusnati, Marco; Dell'Era, Patrizia; Urbinati, Chiara Eva; Tanghetti, Elena; Massardi, Ml; Nagamine, Y; Monti, Eugenio; Presta, Marco
A drug repositioning pipeline to evaluate a synergic effect of small molecules on CFTR drugs 1-gen-2022 D’Ursi P., Uggeri M.; Urbinati, C.; Rusnati, M.; Fossa, P. and Orro A.
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 1-gen-2001 Rusnati, Marco; Urbinati, Chiara Eva; Musulin, B.; Ribatti, D.; Albini, A.; Noonan, D.; Marchisone, C.; Waltenberger, J.; Presta, Marco
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 1-gen-2005 Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 1-gen-2023 Strizzi, Sergio; Bernardo, Letizia; D'Ursi, Pasqualina; Urbinati, Chiara; Bianco, Andrea; Limanaqi, Fiona; Manconi, Andrea; Milanesi, Maria; Macchi, Alberto; Di Silvestre, Dario; Cavalleri, Adalberto; Pareschi, Giovanni; Rusnati, Marco; Clerici, Mario; Mauri, Pierluigi; Biasin, Mara
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 1-gen-2003 Urbinati, Chiara Eva; L., Tassone; Bugatti, Antonella; M., Camozzi; Rusnati, Marco
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 1-gen-2005 Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D.
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 1-gen-1992 Presta, Marco; Rusnati, Marco; J. A. M., Maier; Urbinati, Chiara Eva; M., Statuto; A., Gualandris; A., Pozzi; G., Ragnotti
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 1-gen-2002 Tanghetti, Elena; R., Ria; Dell'Era, Patrizia; Urbinati, Chiara Eva; Rusnati, Marco; M. G., Ennas; Presta, Marco
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 1-gen-1991 Presta, Marco; Rusnati, Marco; Urbinati, Chiara Eva; A., Sommer; G., Ragnotti
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 1-gen-2015 Rusnati, Marco; Chiodelli, Paola; Bugatti, Antonella; Urbinati, Chiara Eva
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 1-gen-2002 Rusnati, Marco; Urbinati, Chiara Eva; Tanghetti, Elena; Dell'Era, Patrizia; LORTAT JACOB, H; Presta, Marco
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 1-gen-2004 Urbinati, Chiara Eva; Bugatti, Antonella; P., Oreste; G., Zoppetti; J., Waltenberger; Mitola, Stefania Maria Filomena; D., Ribatti; Presta, Marco; Rusnati, Marco
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 1-gen-2021 Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P.
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 1-gen-2021 Uggeri, M.; Orro, A.; Urbinati, C.; Rusnati, M.; Fossa P., and D’Ursi P
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 1-gen-2017 Chiodelli, Paola; Rezzola, Sara; Urbinati, Chiara Eva; FEDERICI SIGNORI, Federica; Monti, Eugenio; Ronca, Roberto; Presta, Marco; Rusnati, Marco
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 1-gen-2006 Mitola, Stefania Maria Filomena; Belleri, Mirella; Urbinati, Chiara Eva; Coltrini, Daniela; Sparatore, B; Pedrazzi, M; Melloni, E; Presta, Marco
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 1-gen-2005 Riboldi, Elena; T., Musso; Moroni, Emanuela; Urbinati, Chiara Eva; S., Bernasconi; Rusnati, Marco; L., Adorini; Presta, Marco; Sozzani, Silvano
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 1-gen-2024 Milanesi, Maria; Urbinati, Chiara; Zimmermann, Liv; Oreste, Pasqua; Caccuri, Francesca; Chlandal, Petr; Wade, Rebecca C.; Paiardi, Giulia; Marco Rusnati, And
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 1-gen-2024 Marchioro, C; Canton, M; Budassi, F; Favaro, A; Sturlese, M; Romagnoli, R; Rusnati, M; Urbinati, C; Viola, G; Mariotto, E.